GlassScriptPhysician profile
Ann M Wurst
NPI 1720083736
$2,136.50
in general payments reported to CMS, 2019-2025
30 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $135 · 2021: $443 · 2022: $568 · 2023: $256 · 2024: $177 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $605.09 | 2019-2025 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Mayne Pharma Commercial LLC | $258.26 | 2021-2025 | |
| Therapeuticsmd, INC. | $143.66 | 2019-2022 | |
| Exeltis, USA INC. | $127.72 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $102.55 | 2019-2025 | |
| Daiichi Sankyo INC. | $77.21 | 2020-2022 | |
| Coopersurgical, INC. | $70.77 | 2020-2024 | Paragard T 380a |
| Astellas Pharma US INC | $63.62 | 2022-2024 | Veozah |
| Evofem Biosciences, INC. | $61.85 | 2021-2022 | |
| Hologic Sales and Service, LLC | $59.77 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $56.85 | 2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $51.87 | 2022 | |
| Amag Pharmaceuticals, INC. | $51.43 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $45.36 | 2023 | Myfembree |
| Pfizer INC. | $42.67 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36.19 | 2019 | |
| Optumhealth Care Solutions, LLC | $30.00 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Baxter Healthcare | $27.65 | 2025 | Tisseel |
| Alydia Health | $26.18 | 2021 | |
| Mylan Pharmaceuticals INC. | $23.62 | 2022 | |
| Scynexis, INC. | $22.21 | 2022 | |
| Axsome Therapeutics, INC. | $22.16 | 2025 | Auvelity |
| Organon LLC | $21.50 | 2022-2024 | |
| Shield Therapeutics INC | $17.20 | 2025 | |
| Convatec INC. | $16.94 | 2023 | |
| Millicent US INC | $16.30 | 2024 | Intrarosa |
| Biogen, INC. | $16.22 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $14.33 | 2021 | |
| Boston Scientific Corporation | $13.68 | 2019 | |
| Roche Diagnostics Corporation | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Wurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.